| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DIA.MI - DiaSorin SpA | BUY | 96 @ EUR 96.08 | EUR 9,224 | The ETF bought 96 new shares of DIA.MI (DiaSorin SpA). The shares were bought for an average price of 96.08 compared to the previous average buy price of 95.5952. This is 0.5% higher than average price of previous purchases of DIA.MI. |
| GMAB.CO - | HOLD | 0 @ DKK 170.631 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 170.631. The average price that GMAB.CO shares were previous bought at was DKK 172.977. The current market price is -1.4% lower than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 174,267 (USD $26,482) compared to the previous valuation of however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 21.6816 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 21.6816. The average price that HIK.L shares were previous bought at was GBP 24.2327. The current market price is -10.5% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 39,188 (USD $51,278) compared to the previous valuation of however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 97.4 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 97.4. The average price that IPN.PA shares were previous bought at was EUR 108.128. The current market price is -9.9% lower than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 41,427 (USD $46,991) compared to the previous valuation of Ipsen SA however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 49.2 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 49.2. The average price that ORNBV.HE shares were previous bought at was EUR 51.589. The current market price is -4.6% lower than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 54,537 (USD $61,862) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| SFZN.SW - | HOLD | 0 @ CHF 929.91 | CHF 0 | The current share valuation price of SFZN.SW based on adjusted close was CHF 929.91. The average price that SFZN.SW shares were previous bought at was CHF 1014.44. The current market price is -8.3% lower than average price they were purchased at. The value of the holding in SFZN.SW has increased by CHF 14,248 (USD $17,417) compared to the previous valuation of however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 114.9 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 114.9. The average price that BIM.PA shares were previous bought at was EUR 112.653. The current market price is 2.0% higher than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 21,234 (USD $24,086) compared to the previous valuation of BioMerieux however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 8.17 | EUR 0 | |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ GBP 2.9976 | GBP 0 | The current share valuation price of CTEC.L based on adjusted close was GBP 2.9976. The average price that CTEC.L shares were previous bought at was GBP 2.87216. The current market price is 4.4% higher than average price they were purchased at. The value of the holding in CTEC.L has increased by GBP 96,717 (USD $126,556) compared to the previous valuation of ConvaTec Group PLC however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 49.74 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 49.74. The average price that ERF.PA shares were previous bought at was EUR 48.9037. The current market price is 1.7% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 115,221 (USD $130,697) compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 23.7281 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 23.7281. The average price that SOBI.ST shares were previous bought at was SEK 26.0522. The current market price is -8.9% lower than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 101,220 (USD $10,364) compared to the previous valuation of however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| ZEAL.CO - | HOLD | 0 @ DKK 60.5111 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 60.5111. The average price that ZEAL.CO shares were previous bought at was DKK 78.5672. The current market price is -23.0% lower than average price they were purchased at. The value of the holding in ZEAL.CO has increased by DKK 82,703 (USD $12,568) compared to the previous valuation of however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 30.135 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 30.135. The average price that DEMANT.CO shares were previous bought at was DKK 32.1673. The current market price is -6.3% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 12,915 (USD $1,963) compared to the previous valuation of however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 111 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 111. The average price that TUB.BR shares were previous bought at was EUR 133.283. The current market price is -16.7% lower than average price they were purchased at. The value of the holding in TUB.BR has increased by EUR 23,503 (USD $26,660) compared to the previous valuation of Financiere de Tubize SA however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| EKTA-B.ST - | HOLD | 0 @ SEK 4.38253 | SEK 0 | The current share valuation price of EKTA-B.ST based on adjusted close was SEK 4.38253. The average price that EKTA-B.ST shares were previous bought at was SEK 5.05196. The current market price is -13.3% lower than average price they were purchased at. The value of the holding in EKTA-B.ST has increased by SEK 30,537 (USD $3,127) compared to the previous valuation of however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| ALK-B.CO - | HOLD | 0 @ DKK 19.4069 | DKK 0 | The current share valuation price of ALK-B.CO based on adjusted close was DKK 19.4069. The average price that ALK-B.CO shares were previous bought at was DKK 19.5516. The current market price is -0.7% lower than average price they were purchased at. The value of the holding in ALK-B.CO has increased by DKK 30,701 (USD $4,665) compared to the previous valuation of however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| SECT-B.ST - | HOLD | 0 @ SEK 23.129 | SEK 0 | The current share valuation price of SECT-B.ST based on adjusted close was SEK 23.129. The average price that SECT-B.ST shares were previous bought at was SEK 21.7917. The current market price is 6.1% higher than average price they were purchased at. The value of the holding in SECT-B.ST has increased by SEK 38,147 (USD $3,906) compared to the previous valuation of however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| AFX.DE - Carl Zeiss Meditec AG | HOLD | 0 @ EUR 56.6 | EUR 0 | The current share valuation price of AFX.DE based on adjusted close was EUR 56.6. The average price that AFX.DE shares were previous bought at was EUR 51.2. The current market price is 10.5% higher than average price they were purchased at. The value of the holding in AFX.DE has increased by EUR 40,841 (USD $46,327) compared to the previous valuation of Carl Zeiss Meditec AG however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| TECN.SW - | HOLD | 0 @ CHF 156.276 | CHF 0 | The current share valuation price of TECN.SW based on adjusted close was CHF 156.276. The average price that TECN.SW shares were previous bought at was CHF 192.309. The current market price is -18.7% lower than average price they were purchased at. The value of the holding in TECN.SW has increased by CHF 2,873 (USD $3,512) compared to the previous valuation of however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| BAVA.CO - | HOLD | 0 @ DKK 20.1369 | DKK 0 | The current share valuation price of BAVA.CO based on adjusted close was DKK 20.1369. The average price that BAVA.CO shares were previous bought at was DKK 20.6449. The current market price is -2.5% lower than average price they were purchased at. The value of the holding in BAVA.CO has increased by DKK 19,351 (USD $2,941) compared to the previous valuation of however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| GXI.DE - Gerresheimer AG | HOLD | 0 @ EUR 53 | EUR 0 | The current share valuation price of GXI.DE based on adjusted close was EUR 53. The average price that GXI.DE shares were previous bought at was EUR 68.7246. The current market price is -22.9% lower than average price they were purchased at. The value of the holding in GXI.DE has fallen by EUR 632 (USD $717) compared to the previous valuation of Gerresheimer AG |
| BANB.SW - | HOLD | 0 @ CHF 51.1881 | CHF 0 | The current share valuation price of BANB.SW based on adjusted close was CHF 51.1881. The average price that BANB.SW shares were previous bought at was CHF 54.3418. The current market price is -5.8% lower than average price they were purchased at. The value of the holding in BANB.SW has increased by CHF 7,993 (USD $9,771) compared to the previous valuation of however if the holding was sold on 2025-04-14 this would crystalise an overall loss. |
| AMP.MI - Amplifon SpA | SELL | -950 @ EUR 17.56 | EUR -16,682 | The ETF sold 950 shares of AMP.MI on 2025-04-14. The shares were previously bought for an average price of EUR 20.7139. The Amplifon SpA shares were sold for -15.2% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,996 (USD $3,399) The average price that the ETF previously sold AMP.MI share for is EUR 24.2047 which is higher than the selling price of EUR 17.56 on 2025-04-14. |
| AMBU-B.CO - | SELL | -1,078 @ DKK 15.8711 | DKK -17,109 | The ETF sold 1078 shares of AMBU-B.CO on 2025-04-14. The shares were previously bought for an average price of DKK 16.2983. The shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of DKK 461 (USD $70) The average price that the ETF previously sold AMBU-B.CO share for is DKK so the ETF has sold 1078 shares on 2025-04-14 at a higher price than the previous selling average. |
| SOON.SW - | SELL | -68 @ CHF 253.573 | CHF -17,243 | The ETF sold 68 shares of SOON.SW on 2025-04-14. The shares were previously bought for an average price of CHF 285.779. The shares were sold for -11.3% lower than average price of previous purchases. This resulted in an overall loss of CHF 2,190 (USD $2,677) The average price that the ETF previously sold SOON.SW share for is CHF 332.576 which is higher than the selling price of CHF 253.573 on 2025-04-14. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | SELL | -364 @ EUR 47.64 | EUR -17,341 | The ETF sold 364 shares of REC.MI on 2025-04-14. The shares were previously bought for an average price of EUR 53.243. The Recordati Industria Chimica e Farmaceutica SpA shares were sold for -10.5% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,039 (USD $2,313) The average price that the ETF previously sold REC.MI share for is EUR 50.8336 which is higher than the selling price of EUR 47.64 on 2025-04-14. |
| QIA.DE - QIAGEN NV | SELL | -467 @ EUR 37.135 | EUR -17,342 | The ETF sold 467 shares of QIA.DE on 2025-04-14. The shares were previously bought for an average price of EUR 42.7392. The QIAGEN NV shares were sold for -13.1% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,617 (USD $2,969) The average price that the ETF previously sold QIA.DE share for is EUR 42.39 which is higher than the selling price of EUR 37.135 on 2025-04-14. |
| SN.L - Smith & Nephew PLC | SELL | -1,510 @ GBP 11.5194 | GBP -17,394 | The ETF sold 1510 shares of SN.L on 2025-04-14. The shares were previously bought for an average price of GBP 11.9511. The Smith & Nephew PLC shares were sold for -3.6% lower than average price of previous purchases. This resulted in an overall loss of GBP 652 (USD $853) The average price that the ETF previously sold SN.L share for is GBP 12.1058 which is higher than the selling price of GBP 11.5194 on 2025-04-14. |
| GALD.SW - | SELL | -206 @ CHF 84.5959 | CHF -17,427 | The ETF sold 206 shares of GALD.SW on 2025-04-14. The shares were previously bought for an average price of CHF 106.599. The shares were sold for -20.6% lower than average price of previous purchases. This resulted in an overall loss of CHF 4,533 (USD $5,541) The average price that the ETF previously sold GALD.SW share for is CHF 90.916 which is higher than the selling price of CHF 84.5959 on 2025-04-14. |
| STMN.SW - | SELL | -167 @ CHF 104.486 | CHF -17,449 | The ETF sold 167 shares of STMN.SW on 2025-04-14. The shares were previously bought for an average price of CHF 114.879. The shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of CHF 1,736 (USD $2,122) The average price that the ETF previously sold STMN.SW share for is CHF 119.715 which is higher than the selling price of CHF 104.486 on 2025-04-14. |
| SRT3.DE - Sartorius AG | SELL | -93 @ EUR 190.25 | EUR -17,693 | The ETF sold 93 shares of SRT3.DE on 2025-04-14. The shares were previously bought for an average price of EUR 219.465. The Sartorius AG shares were sold for -13.3% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,717 (USD $3,082) The average price that the ETF previously sold SRT3.DE share for is EUR 215.039 which is higher than the selling price of EUR 190.25 on 2025-04-14. |
| SHL.DE - Siemens Healthineers AG | SELL | -400 @ EUR 44.3 | EUR -17,720 | The ETF sold 400 shares of SHL.DE on 2025-04-14. The shares were previously bought for an average price of EUR 51.5254. The Siemens Healthineers AG shares were sold for -14.0% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,890 (USD $3,278) The average price that the ETF previously sold SHL.DE share for is EUR 49.509 which is higher than the selling price of EUR 44.3 on 2025-04-14. |
| FME.DE - Fresenius Medical Care AG | SELL | -408 @ EUR 43.57 | EUR -17,777 | The ETF sold 408 shares of FME.DE on 2025-04-14. The shares were previously bought for an average price of EUR 44.555. The Fresenius Medical Care AG shares were sold for -2.2% lower than average price of previous purchases. This resulted in an overall loss of EUR 402 (USD $456) The average price that the ETF previously sold FME.DE share for is EUR 41.0072 so the ETF has sold 408 shares on 2025-04-14 at a higher price than the previous selling average. |
| GETI-B.ST - | SELL | -1,004 @ SEK 17.7098 | SEK -17,781 | The ETF sold 1004 shares of GETI-B.ST on 2025-04-14. The shares were previously bought for an average price of SEK 18.4135. The shares were sold for -3.8% lower than average price of previous purchases. This resulted in an overall loss of SEK 707 (USD $72) The average price that the ETF previously sold GETI-B.ST share for is SEK so the ETF has sold 1004 shares on 2025-04-14 at a higher price than the previous selling average. |
| DIM.PA - Sartorius Stedim Biotech | SELL | -105 @ EUR 170 | EUR -17,850 | The ETF sold 105 shares of DIM.PA on 2025-04-14. The shares were previously bought for an average price of EUR 186.847. The Sartorius Stedim Biotech shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of EUR 1,769 (USD $2,007) The average price that the ETF previously sold DIM.PA share for is EUR 173.227 which is higher than the selling price of EUR 170 on 2025-04-14. |
| COLO-B.CO - | SELL | -201 @ DKK 93.0033 | DKK -18,694 | The ETF sold 201 shares of COLO-B.CO on 2025-04-14. The shares were previously bought for an average price of DKK 98.9579. The shares were sold for -6.0% lower than average price of previous purchases. This resulted in an overall loss of DKK 1,197 (USD $182) The average price that the ETF previously sold COLO-B.CO share for is DKK 97.8949 which is higher than the selling price of DKK 93.0033 on 2025-04-14. |
| MRK.DE - Merck KGaA | SELL | -167 @ EUR 117.55 | EUR -19,631 | The ETF sold 167 shares of MRK.DE on 2025-04-14. The shares were previously bought for an average price of EUR 125.212. The Merck KGaA shares were sold for -6.1% lower than average price of previous purchases. This resulted in an overall loss of EUR 1,280 (USD $1,451) The average price that the ETF previously sold MRK.DE share for is EUR 141.523 which is higher than the selling price of EUR 117.55 on 2025-04-14. |
| SDZ.SW - | SELL | -573 @ CHF 35.2268 | CHF -20,185 | The ETF sold 573 shares of SDZ.SW on 2025-04-14. The shares were previously bought for an average price of CHF 40.3859. The shares were sold for -12.8% lower than average price of previous purchases. This resulted in an overall loss of CHF 2,956 (USD $3,614) The average price that the ETF previously sold SDZ.SW share for is CHF 42.301 which is higher than the selling price of CHF 35.2268 on 2025-04-14. |
| FRE.DE - Fresenius SE & Co KGaA | SELL | -535 @ EUR 38.23 | EUR -20,453 | The ETF sold 535 shares of FRE.DE on 2025-04-14. The shares were previously bought for an average price of EUR 37.485. The Fresenius SE & Co KGaA shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of EUR 399 (USD $452) The average price that the ETF previously sold FRE.DE share for is EUR 34.2924 so the ETF has sold 535 shares on 2025-04-14 at a higher price than the previous selling average. |
| PHIA.AS - Koninklijke Philips NV | SELL | -1,010 @ EUR 21.03 | EUR -21,240 | The ETF sold 1010 shares of PHIA.AS on 2025-04-14. The shares were previously bought for an average price of EUR 23.8839. The Koninklijke Philips NV shares were sold for -11.9% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,882 (USD $3,270) The average price that the ETF previously sold PHIA.AS share for is EUR 24.5752 which is higher than the selling price of EUR 21.03 on 2025-04-14. |
| UCB.BR - UCB SA | SELL | -159 @ EUR 139.1 | EUR -22,117 | The ETF sold 159 shares of UCB.BR on 2025-04-14. The shares were previously bought for an average price of EUR 165.159. The UCB SA shares were sold for -15.8% lower than average price of previous purchases. This resulted in an overall loss of EUR 4,143 (USD $4,700) The average price that the ETF previously sold UCB.BR share for is EUR 173.752 which is higher than the selling price of EUR 139.1 on 2025-04-14. |
| NSIS-B.CO - | SELL | -452 @ DKK 54.0823 | DKK -24,445 | The ETF sold 452 shares of NSIS-B.CO on 2025-04-14. The shares were previously bought for an average price of DKK 53.0372. The shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of DKK 472 (USD $72) The average price that the ETF previously sold NSIS-B.CO share for is DKK 54.8464 which is higher than the selling price of DKK 54.0823 on 2025-04-14. |
| BAYN.DE - Bayer AG | SELL | -1,268 @ EUR 20.89 | EUR -26,489 | The ETF sold 1268 shares of BAYN.DE on 2025-04-14. The shares were previously bought for an average price of EUR 20.6024. The Bayer AG shares were sold for 1.4% higher than average price of previous purchases. This sale made a profit of EUR 365 (USD $414) The average price that the ETF previously sold BAYN.DE share for is EUR 20.9009 which is higher than the selling price of EUR 20.89 on 2025-04-14. |
| ARGX.BR - Argenx SE | SELL | -77 @ EUR 527.4 | EUR -40,610 | The ETF sold 77 shares of ARGX.BR on 2025-04-14. The shares were previously bought for an average price of EUR 562.164. The Argenx SE shares were sold for -6.2% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,677 (USD $3,036) The average price that the ETF previously sold ARGX.BR share for is EUR 539.38 which is higher than the selling price of EUR 527.4 on 2025-04-14. |
| HLN.L - Haleon PLC | SELL | -10,704 @ GBP 4.39663 | GBP -47,062 | The ETF sold 10704 shares of HLN.L on 2025-04-14. The shares were previously bought for an average price of GBP 4.61467. The Haleon PLC shares were sold for -4.7% lower than average price of previous purchases. This resulted in an overall loss of GBP 2,334 (USD $3,054) The average price that the ETF previously sold HLN.L share for is GBP 4.42037 which is higher than the selling price of GBP 4.39663 on 2025-04-14. |
| ALC.SW - | SELL | -632 @ CHF 79.7742 | CHF -50,417 | The ETF sold 632 shares of ALC.SW on 2025-04-14. The shares were previously bought for an average price of CHF 82.3493. The shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of CHF 1,627 (USD $1,989) The average price that the ETF previously sold ALC.SW share for is CHF 82.6548 which is higher than the selling price of CHF 79.7742 on 2025-04-14. |
| LONN.SW - | SELL | -90 @ CHF 572.368 | CHF -51,513 | The ETF sold 90 shares of LONN.SW on 2025-04-14. The shares were previously bought for an average price of CHF 588.16. The shares were sold for -2.7% lower than average price of previous purchases. This resulted in an overall loss of CHF 1,421 (USD $1,737) The average price that the ETF previously sold LONN.SW share for is CHF 556.057 so the ETF has sold 90 shares on 2025-04-14 at a higher price than the previous selling average. |
| GSK.L - GlaxoSmithKline PLC | SELL | -5,437 @ GBP 15.3418 | GBP -83,413 | The ETF sold 5437 shares of GSK.L on 2025-04-14. The shares were previously bought for an average price of GBP 16.412. The GlaxoSmithKline PLC shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of GBP 5,819 (USD $7,613) The average price that the ETF previously sold GSK.L share for is GBP 16.049 which is higher than the selling price of GBP 15.3418 on 2025-04-14. |
| EL.PA - EssilorLuxottica SA | SELL | -389 @ EUR 247.1 | EUR -96,122 | The ETF sold 389 shares of EL.PA on 2025-04-14. The shares were previously bought for an average price of EUR 260.835. The EssilorLuxottica SA shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of EUR 5,343 (USD $6,060) The average price that the ETF previously sold EL.PA share for is EUR 228.451 so the ETF has sold 389 shares on 2025-04-14 at a higher price than the previous selling average. |
| SAN.PA - Sanofi SA | SELL | -1,474 @ EUR 91.88 | EUR -135,431 | The ETF sold 1474 shares of SAN.PA on 2025-04-14. The shares were previously bought for an average price of EUR 101.196. The Sanofi SA shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of EUR 13,732 (USD $15,575) The average price that the ETF previously sold SAN.PA share for is EUR 92.9885 which is higher than the selling price of EUR 91.88 on 2025-04-14. |
| AZN.L - AstraZeneca PLC | SELL | -1,940 @ GBP 119.718 | GBP -232,253 | The ETF sold 1940 shares of AZN.L on 2025-04-14. The shares were previously bought for an average price of GBP 130.456. The AstraZeneca PLC shares were sold for -8.2% lower than average price of previous purchases. This resulted in an overall loss of GBP 20,832 (USD $27,259) The average price that the ETF previously sold AZN.L share for is GBP 123.561 which is higher than the selling price of GBP 119.718 on 2025-04-14. |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -3,991 @ DKK 58.3748 | DKK -232,974 | The ETF sold 3991 shares of NOVO-B.CO on 2025-04-14. The shares were previously bought for an average price of DKK 67.492. The Novo Nordisk A/S shares were sold for -13.5% lower than average price of previous purchases. This resulted in an overall loss of DKK 36,387 (USD $5,529) The average price that the ETF previously sold NOVO-B.CO share for is DKK 70.7375 which is higher than the selling price of DKK 58.3748 on 2025-04-14. |
| NOVN.SW - | SELL | -2,465 @ CHF 95.5095 | CHF -235,431 | The ETF sold 2465 shares of NOVN.SW on 2025-04-14. The shares were previously bought for an average price of CHF 98.3879. The shares were sold for -2.9% lower than average price of previous purchases. This resulted in an overall loss of CHF 7,095 (USD $8,673) The average price that the ETF previously sold NOVN.SW share for is CHF 97.8175 which is higher than the selling price of CHF 95.5095 on 2025-04-14. |
| ROG.SW - | SELL | -879 @ CHF 270.901 | CHF -238,122 | The ETF sold 879 shares of ROG.SW on 2025-04-14. The shares were previously bought for an average price of CHF 288.84. The shares were sold for -6.2% lower than average price of previous purchases. This resulted in an overall loss of CHF 15,768 (USD $19,276) The average price that the ETF previously sold ROG.SW share for is CHF 275.957 which is higher than the selling price of CHF 270.901 on 2025-04-14. |